Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0885066620969132 http://scihub22266oqcxt.onion/10.1177/0885066620969132 33111601!ä!33111601 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Intensive+Care+Med 2021 ; 36 (1): 18-41 Nephropedia Template TP {{tp|p=33111601|t=2021. Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection |pdf=|usr=}}{{33111601}} gab.com Text Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection JO: J Intensive Care Med http://www.kidney.de/pget.php?&tw=1&pmid=33111601 #FOAvip Human infection by the novel viral pathogen SARS-CoV-2 results in a clinical syndrome termed Coronavirus Disease 2019 (COVID-19). Although the majority of COVID-19 cases are self-limiting, a substantial minority of patients develop disease severe enough to require intensive care. Features of critical illness associated with COVID-19 include hypoxemic respiratory failure, acute respiratory distress syndrome (ARDS), shock, and multiple organ dysfunction syndrome (MODS). In most (but not all) respects critically ill patients with COVID-19 resemble critically ill patients with ARDS due to other causes and are optimally managed with standard, evidence-based critical care protocols. However, there is naturally an intense interest in developing specific therapies for severe COVID-19. Here we synthesize the rapidly expanding literature around the pathophysiology, clinical presentation, and management of COVID-19 with a focus on those points most relevant for intensivists tasked with caring for these patients. We specifically highlight evidence-based approaches that we believe should guide the identification, triage, respiratory support, and general ICU care of critically ill patients infected with SARS-CoV-2. In addition, in light of the pressing need and growing enthusiasm for targeted COVID-19 therapies, we review the biological basis, plausibility, and clinical evidence underlying these novel treatment approaches. Twit Text FOAVip Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection ????J Intensive Care Med http://www.kidney.de/pget.php?&tw=1&pmid=33111601 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33111601 #FOAvip English Wikipedia <ref>{{Cite pmid|33111601}}</ref> Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection #MMPMID33111601 Chivukula RR; Maley JH; Dudzinski DM; Hibbert K; Hardin CC J Intensive Care Med 2021[Jan]; 36 (1): 18-41 PMID33111601show ga Human infection by the novel viral pathogen SARS-CoV-2 results in a clinical syndrome termed Coronavirus Disease 2019 (COVID-19). Although the majority of COVID-19 cases are self-limiting, a substantial minority of patients develop disease severe enough to require intensive care. Features of critical illness associated with COVID-19 include hypoxemic respiratory failure, acute respiratory distress syndrome (ARDS), shock, and multiple organ dysfunction syndrome (MODS). In most (but not all) respects critically ill patients with COVID-19 resemble critically ill patients with ARDS due to other causes and are optimally managed with standard, evidence-based critical care protocols. However, there is naturally an intense interest in developing specific therapies for severe COVID-19. Here we synthesize the rapidly expanding literature around the pathophysiology, clinical presentation, and management of COVID-19 with a focus on those points most relevant for intensivists tasked with caring for these patients. We specifically highlight evidence-based approaches that we believe should guide the identification, triage, respiratory support, and general ICU care of critically ill patients infected with SARS-CoV-2. In addition, in light of the pressing need and growing enthusiasm for targeted COVID-19 therapies, we review the biological basis, plausibility, and clinical evidence underlying these novel treatment approaches. |Adult[MESH] |COVID-19/complications/physiopathology/*therapy[MESH] |Critical Care/*methods[MESH] |Critical Illness/*therapy[MESH] |Evidence-Based Practice/methods[MESH] |Humans[MESH]Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing